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SimC7 is a polyketide ketoreductase involved in
biosynthesis of the angucyclinone moiety of the gyr-
ase inhibitor simocyclinone D8 (SD8). SimC7, which
belongs to the short-chain dehydrogenase/reductase
(SDR) superfamily, catalyzes reduction of the C-7
carbonyl of the angucyclinone, and the resulting hy-
droxyl is essential for antibiotic activity. SimC7 shares
little sequence similarity with characterized ketore-
ductases, suggesting it might have a distinct mecha-
nism. To investigate this possibility, we determined
the structures of SimC7 alone, with NADP+, and with
NADP+ and the substrate 7-oxo-SD8. These struc-
tures show that SimC7 is distinct from previously
characterized polyketide ketoreductases, lacking
the conserved catalytic triad, including the active-
site tyrosine that acts as central acid-base catalyst
in canonical SDR proteins. Taken together with func-
tional analyses of active-site mutants, our data sug-
gest that SimC7 catalyzes a substrate-assisted, two-
step reaction for reduction of the C-7 carbonyl group
involving intramolecular transfer of a substrate-
derived proton to generate a phenolate intermediate.
INTRODUCTION
Angucyclin(on)es form the largest group of polycyclic aromatic
polyketides, many with anticancer and antibacterial activities
(Kharel et al., 2012). They share a polyketide-derived tetracyclic
benz[a]anthracene carbon skeleton, but numerous structures
are generated by a range of tailoring reactions, including O-
or C-linked deoxysugar glycosylation to form angucyclines. In
general, these tailoring enzymes are not well understood. An
important challenge, therefore, is to define the step catalyzed
by each enzyme and to determine their reaction mechanisms.
This knowledge is particularly relevant to the rational engineering
of angucyclin(on)e biosynthetic pathways for novel therapeutics.
Simocyclinone D8 (SD8) is a potent DNA gyrase inhibitor
isolated from Streptomyces antibioticus that consists of an an-
gucyclinone connected to a chlorinated aminocoumarin via a
D-olivose deoxysugar and a tetraene diester linker (Figure 1)Cell Chemical Biology 23, 1091–1097, Septemb
This is an open access article und(Schimana et al., 2000; Edwards et al., 2009; Hearnshaw et al.,
2014). SD8 is bifunctional, with the angucyclinone and the ami-
nocoumarin at opposite ends of the molecule binding to two
distinct pockets on the DNA binding surface of the GyrA subunit
of gyrase (Edwards et al., 2009; Hearnshaw et al., 2014), thereby
inhibiting DNA supercoiling at submicromolar concentrations
(Edwards et al., 2011). Because gyrase is essential in bacteria
but absent fromhumans, it is an attractive target for antimicrobial
drugs, as exemplified by the clinically successful fluoroquino-
lones (Collin et al., 2011).
SimC7 was originally annotated as a dehydratase and pre-
dicted to be involved in the biosynthesis of the tetraene linker of
SD8 (Trefzer et al., 2002). However, we recently showed that
SimC7 is in fact an NAD(P)H-dependent ketoreductase that cat-
alyzes the reduction of a carbonyl to a hydroxyl group at the C-7
position of the angucyclinone (Scha¨fer et al., 2015). This enzy-
matic step is essential for antibiotic activity, converting thealmost
inactive 7-oxo-simocyclinone D8 (7-oxo-SD8; half maximal
inhibitory concentration [IC50] 50–100 mM) into the potent gyr-
ase inhibitor SD8 (IC50 0.1–0.6 mM) (Scha¨fer et al., 2015).
Based on the intermediates produced by S. antibioticus, it
seems that the biosynthesis of SD8 starts with assembly of the
angucyclinone, followed by the attachment of the deoxysugar,
then the tetraene linker, and finally the aminocoumarin (i.e.,
SD8 is assembled from right to left in Figure 1) (Schimana
et al., 2001). Therefore, the physiological substrate of SimC7 is
most likely a 7-oxo angucyclinone intermediate lacking the
attached deoxysugar, tetraene linker, and aminocoumarin, an in-
termediate that is detectable only in DsimC7 mutants (Scha¨fer
et al., 2015). Despite this, the enzyme readily accepts as a sub-
strate the full-length intermediate 7-oxo-SD8, the major product
made by DsimC7 mutants (Scha¨fer et al., 2015).
The angucyclinone moiety of SD8 is synthesized by a type II
polyketide synthase (SimA1-3) and multiple tailoring enzymes
(SimA4-13, SimC7) that catalyze cyclization, aromatization,
oxidation, and reduction reactions. Several ketoreductases of
the short-chain dehydrogenase/reductase (SDR) family that act
on angucyclinones or related polyketides have been character-
ized. The reduction of carbonyl groups at the C-6 and C-9 posi-
tions of polyketides has been functionally characterized, and the
structures of the corresponding SDR enzymes have elucidated
their reaction mechanisms and factors determining their stereo-
selectivity. The ketoreductases LanV and UrdMred act on the
C-6 carbonyl group of angucyclic polyketides from the landomy-
cin and urdamycin pathways (Paananen et al., 2013; Patrikainener 22, 2016 ª 2016 The Author(s). Published by Elsevier Ltd. 1091
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. SimC7 Catalyzes the Reduction of 7-oxo-SD8 to Simocy-
clinone D8
A, B, C, and D denote the four rings of the angucyclinone moiety; the C-7
carbonyl/hydroxyl is highlighted in red.
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act on the C-9 carbonyl group of early intermediates in the acti-
norhodin and hedamycin polyketide pathways (Javidpour et al.,
2011a, 2011b, 2013; Korman et al., 2004, 2008). The LanV,
UrdMred, ActKR, and HedKR structures revealed the catalytic
Ser-Tyr-Lys triad characteristic of SDR enzymes, where the
latter two residues form a YxxxK motif. In these classical SDR
proteins, the conserved active-site tyrosine serves as central
acid-base catalyst that donates a proton to the substrate. The
adjacent lysine residue lowers the pKa of the tyrosine hydroxyl
group and often contributes directly to a proton relay mecha-
nism, and the hydroxyl group of the serine stabilizes and polar-
izes the carbonyl group of the substrate (Kavanagh et al., 2008).
At the sequence level, SimC7 shares little similarity with any
characterized ketoreductase, even with functionally analogous
polyketide ketoreductases. The striking differences between
the amino acid sequence of SimC7 and those of HedKR, ActKR,
LanV, and UrdMred suggested that SimC7 might have a novel
catalytic mechanism. To investigate this possibility, we deter-
mined the structures of SimC7 alone (apo; 1.6 A˚ resolution),
the binary complex with NADP+ (1.95 A˚), and the ternary com-
plex with both NADP+ and 7-oxo-SD8 (1.2 A˚) (Tables S1 and
S2). Our results reveal that SimC7 is structurally distinct from
previously characterized polyketide ketoreductases and, impor-
tantly, lacks the canonical SDR Ser-Tyr-Lys catalytic triad (Kava-
nagh et al., 2008; Kallberg et al., 2010; Persson and Kallberg,
2013). Instead, our data suggest that SimC7 catalyzes a sub-
strate-assisted, two-step reaction for the reduction of the C-7
carbonyl group involving an unusual phenolate intermediate.
RESULTS AND DISCUSSION
Overall Structure of SimC7
SimC7 is made up of two domains, the larger of which is the
nucleotide binding domain that adopts a Rossmann fold (Figures1092 Cell Chemical Biology 23, 1091–1097, September 22, 20162A, 2B, and S1); the smaller substrate binding domain, charac-
teristic of the so-called extended SDR subfamily (Kavanagh
et al., 2008), is mainly a-helical and is largely formed by two in-
sertions in the nucleotide binding domain (between b6 and a6,
and between b9 and a10). Notably, the latter insertion contains
a ‘‘lid’’ motif consisting of two antiparallel a helices (a8 and a9)
that folds over the active site (Figures 2A, 2B, and S1). The sub-
strate binding domain is completed by a short helical segment at
the C-terminus of the polypeptide chain.
Overall the apo, binary, and ternary SimC7 structures are very
similar (Table S3), with the notable exception of the lid motif,
which displays a number of different conformations (Figure 2C).
Although the changes are not large (maximum Ca-Ca shift
5.35 A˚; Table S3), there is a clear closure of the lid over the bound
substrate (Figure 2C), suggesting a role in gating access to the
active site and/or substrate capture. Moreover, in the ternary
complex the underside of the lid contributes to the tight, highly
hydrophobic substrate binding pocket (Figure 3) that provides
the necessary environment for catalysis (see below).
Structural Homologs of SimC7
Structures annotated as SDR proteins (PFAM family PF00106)
are prevalent in the PDB, with more than 600 entries. To look
for structural homologs of SimC7, we carried out a structure-
based similarity search using the DALI server (Table S4). Strik-
ingly, characterized angucyclinone ketoreductases ranked very
low in the search, the closest match being LanV (Figure S2A),
which was the 166th ranked hit after filtering for sequence redun-
dancy (Table S4). Instead, the two most structurally similar
proteins to SimC7 were quinone oxidoreductase (QOR2) from
Escherichia coli (PDB: 2ZCV) (Kim et al., 2008a) (Figure S2A)
and triphenylmethane reductase (TMR) from Citrobacter sp.
KCTC 18061P (PDB: 2VRB) (Kim et al., 2008b). QOR2 and TMR
sharewithSimC7 the ability to reduce substrateswith extensively
conjugated pi systems but have roles in the detoxification of
xenobiotics rather than the biosynthesis of natural products.
Themajority of the closest structural homologs of known function
are involved in sugar biosynthesis, many of them epimerases.
SimC7 and its closest structural homologs all fall into the
extended SDR subfamily of proteins, characterized by having
two distinct domains that together form a partially occluded
active-site pocket at their junction (Figure S2A). In contrast,
the other structurally characterized polyketide ketoreductases
such as LanV are more distantly related and belong to the clas-
sical SDR subfamily (Kavanagh et al., 2008), in which three inser-
tions within the core Rossmann fold motif delineate a more
accessible active-site cavity but do not constitute a well-defined
substrate binding domain (Figure S2A).
Substrate Binding
In the ternary complex with substrate, determined at 1.2-A˚ reso-
lution, the angucyclic ring system of 7-oxo-SD8 binds adjacent
and parallel to the nicotinamide ring of the cofactor (Figures
2D, 2E, and S3), where it adopts a relatively planar conformation
differing from the conformations seen in the DNA gyrase-SD8
and SimR-SD8 complexes, in which the A ring of the angucycli-
none in SD8 is tilted upward toward the epoxide (Hearnshaw
et al., 2014; Le et al., 2011) (Figure S2B). This planar conforma-
tion is most likely enforced by the shape of the very constricted
Figure 2. Crystal Structure of SimC7
(A and B) SimC7 displayed as (A) amolecular surface and (B) cartoon representationwith the nucleotide binding domain, the substrate binding domain, and the lid
motif shown in pale blue, beige, andmagenta, respectively. Ligands are represented as van derWaals spheres with the 7-oxo-SD8 substrate shown in yellow and
the cofactor shown in green.
(C) Close-up showing conformational changes in the lid between the apo (chain A, form 2; blue), the binary complex (salmon), and the ternary complex (magenta);
the core protein structure and ligands shown represent the ternary complex. C-4 of the cofactor and C-7 of the substrate are highlighted by black spheres,
showing that C-7 of the substrate is exactly positioned 3 A˚ from C-4 of the nicotinamide ring, poised for direct hydride transfer.
(D and E) Orthogonal close-ups showing the active site of the ternary complex including the Ser95-Ile108-His112 ‘‘catalytic triad’’ residues, and Asn137, which is
important in maintaining the syn conformation of the cofactor. For clarity, only the angucyclic polyketide moiety of the substrate is shown. Hydrogen bonds are
shown as dashed lines. (E) is also reproduced as a stereo image in Figures S3A and S3B, which also show a difference electron density map calculated from the
final model after simulated annealing refinement with the substrate omitted.
See also Figures S1–S4 and Tables S1–S3.
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Biology (2016), http://dx.doi.org/10.1016/j.chembiol.2016.07.018and highly hydrophobic substrate pocket (Figure 3). Within this
hydrophobic pocket, 7-oxo-SD8 is bound only by a single direct
hydrogen bond between the side chain of Ser95 and the C-7
carbonyl oxygen of the angucyclinone moiety, which may help
to position the latter exactly above the C-4 position of the nico-
tinamide ring, where it is poised for direct hydride transfer (high-lighted by black spheres in Figures 2C–2E, 3B, and S3). As
mentioned above, the natural substrate for SimC7 is likely to
be a 7-oxo angucyclinone intermediate lacking the deoxysugar,
the tetraene linker, and the aminocoumarin. Consistent with this,
only the angucyclinone moiety is buried in the active site of
SimC7. Roughly half of the tetraene linker is visible in the electronCell Chemical Biology 23, 1091–1097, September 22, 2016 1093
Figure 3. SimC7 Has a Very Hydrophobic and Constricted Substrate Binding Pocket
(A) The substrate is bound by only one direct hydrogen bond between the C-7 carbonyl group (red) in the angucyclinone moiety and the side-chain hydroxyl of
Ser95. This interactionmay assist in positioning the substrate and facilitating the reaction. Interacting residues are shown in black (side-chain interactions) or blue
(backbone interactions). The hydrophobic residues shown in gray line the entrance to the substrate pocket but do not interact directly with the bound angu-
cyclinone. Note that one face of the pocket is formed by the cofactor itself (not shown). In the natural SimC7 substrate R=H, in the substrate used here R includes
the deoxysugar, tetraene linker, and the aminocoumarin.
(B) Orthogonal cross-sections through the active-site pocket, revealing how tightly cofactor (green) and substrate (yellow) are bound. For clarity, only the
nicotinamide ribosyl moiety of the cofactor and the polyketide moiety of the substrate are shown. In (I) and (III) the view corresponds roughly to that shown in
Figure 2D, whereas (II) and (IV) show the view from above relative to Figure 2D. In the lower panels, C-4 of the cofactor and C-7 of the substrate are highlighted by
black spheres, showing that C-7 of the substrate is exactly positioned 3 A˚ from C-4 of the nicotinamide ring, poised for hydride transfer.
See also Figures S1–S3.
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nocoumarin ring is not resolved at all (Figure S3).
A Novel Catalytic Mechanism for a Polyketide
Ketoreductase
SimC7 lacks the Ser-Tyr-Lys catalytic triad characteristic of ca-
nonical SDR proteins (Figure 4 and Table S4). While the serine is
conserved (Ser95), the other two residues (i.e., the YxxxK motif)
are not, being instead replaced by Ile108 and His112, respec-
tively. This Ser-Ile-His triad is unlike any described for the five
subfamilies of SDRs defined by Kavanagh et al. (2008). Particu-
larly surprising is the absence of the tyrosine residue that acts as
the acid-base catalyst in the classical SDR mechanism (Fig-
ure 4A). Inspection of the structure of the ternary complex shows
that none of the five tyrosine residues in SimC7 is sufficiently
close to C-7 of the angucyclinone ring system of the substrate
to play a direct role in catalysis. Furthermore, the structure also
shows that there is no alternative residue that could act as an
acid-base catalyst. Consequently, SimC7 must perform ketore-
duction of 7-oxo-SD8 via a novel mechanism.
Based on the structure of the ternary complex of the enzyme
with NADP+ and 7-oxo-SD8, we propose a simple two-step
mechanism for SimC7 that does not depend on catalytic resi-
dues in the protein, but rather takes advantage of the specific
properties of the substrate itself, and is thus a novel example
of substrate-assisted catalysis (Dall’Acqua and Carter, 2000).1094 Cell Chemical Biology 23, 1091–1097, September 22, 2016In the first step, the hydrophobic environment of the substrate
binding pocket and the juxtaposition of the quinone-like C ring
and the phenyl-like D ring of the angucyclinone favor the forma-
tion of an intramolecular hydrogen bond between the proton on
the C-8 hydroxyl group and the oxygen of the neighboring C-7
carbonyl group (Figure 4B). This enhances the polarization of
the latter such that the electrophilicity of C-7 is increased, mak-
ing it a good acceptor for direct hydride transfer from the 4-pro-S
position of the nicotinamide ring. Crucially, the hydride donor
and acceptor carbon atoms are only 3.0 A˚ apart in the crystal
structure. The C-7 hydroxyl group is then formed by internal pro-
ton transfer from the neighboring C-8 hydroxyl group, generating
a phenolate intermediate in which the negative charge on the C-8
oxygen atom is stabilized by the aromatic D ring. In the second
step of the reaction, the phenolate intermediate leaves the sub-
strate binding pocket and the proton required to reinstate the
C-8 hydroxyl group is recovered by abstraction from bulk water,
which is not possible within the confines of the active site (Fig-
ure 4B). Exchange of the negatively charged reaction intermedi-
ate is most likely accelerated by repulsion from the hydrophobic
active-site cavity. Finally, the direct hydride attack from below
the angucyclic polyketide unambiguously explains the 7S ste-
reochemistry of simocyclinones. In support of this proposed
mechanism, molecular modeling predicts the existence of the
key intramolecular hydrogen bond between the C-8 hydroxyl
group and the C-7 carbonyl group of 7-oxo-SD8, and an
Figure 4. Canonical SDR Ketoreduction and the Novel SimC7 Reaction Mechanism
(A) In canonical SDR proteins the conserved active-site tyrosine serves as central acid-base catalyst that donates a proton to the substrate. The adjacent lysine
residue lowers the pKa of the tyrosine hydroxyl group and often contributes directly to the proton relay mechanism; the hydroxyl group of the serine stabilizes and
polarizes the carbonyl group of the substrate.
(B) SimC7 has an atypical catalytic triad comprised of Ser95, Ile108, andHis112. In the first step of the proposed SimC7mechanism, the C-7 carbonyl group of the
substrate (7-oxo-SD8) is reduced by transfer of the 4-pro-S hydride of the cofactor onto the C-7 carbon of the substrate. This transfer frombelow theC ring results
in the characteristic 7-S stereochemistry of SD8. Ketoreduction at position C-7 is completed by an intramolecular proton transfer from the neighboring C-8
hydroxyl group of the angucyclinone; the resultant negative charge on the latter is stabilized by the adjacent aromatic ring system (ring D in Figure 1). In the second
step, the C-8 phenolate intermediate regains a proton from bulk water after leaving the substrate binding pocket. In the natural SimC7 substrate R=H, in the
substrate used here R includes the deoxysugar, tetraene linker, and the aminocoumarin. Note that there are no water molecules in the active-site pocket that
could contribute to the reactionmechanism. In the ternary complex, the nearest water toO-7 of the angucyclic polyketide is5.5 A˚ away, and the nearest water to
O-8 is4.9 A˚ away. Due to steric constraints within the pocket, neither could approach the substrate oxygen atomswithout either a repositioning of the substrate
or a conformational change in the protein.
(C) Enzymatic activities of SimC7 active-site mutants. Standard errors are indicated for three independent experiments.
See also Figures S3 and S4; Table S4.
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small-molecule crystal structure of panglimycin, a closely related
polyketide (Fotso et al., 2008). Furthermore, molecular modeling
also predicts that the C-8 hydroxyl group will have the most
acidic and exchangeable proton in the angucyclic polyketide,
with an estimated pKa of 6.9–7.7, and therefore could readily
transfer to the neighboring C-7 oxygen at the end of step 1.
Indeed, there is no other possible proton donor (neither protein
nor water derived) sufficiently close to O-7 to perform this role.
Based on their structures (Figure S4A), there are four other an-
gucyclinones in which a SimC7-like mechanism might generateaC-7 hydroxyl group: panglimycin, elmycin, grisemycin, and kia-
mycin (Fotso et al., 2008; Xie et al., 2012, 2016). However, the
biosynthetic gene clusters for these molecules have yet to be
reported, and it is not known whether a SimC7-like enzyme is
involved in their synthesis. Most other angucyclin(on)es have a
carbonyl group at C-7.
Mutagenesis of the SimC7 Active Site
To investigate the potential roles of the SimC7 ‘‘catalytic triad’’
residues in the proposed reaction mechanism, we mutagenized
Ser95, Ile108, and His112 (Figure 4B). In the wild-type enzyme,Cell Chemical Biology 23, 1091–1097, September 22, 2016 1095
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Biology (2016), http://dx.doi.org/10.1016/j.chembiol.2016.07.018the hydroxyl group of Ser95 could aid catalysis by helping to bind
and correctly orient the substrate, and by providing additional
polarization to the C-7 carbonyl group via a hydrogen bond,
the latter role being consistent with the function proposed for
the structurally equivalent Ser/Thr residues in the classical
SDR mechanism (Figure 4A) (Kavanagh et al., 2008; Kallberg
et al., 2010; Persson and Kallberg, 2013). However, neither effect
would appear to be crucial for activity, as a S95Amutant showed
86% substrate conversion relative to the wild-type (Figure 4C).
Therefore, SimC7 must be able to orient 7-oxo-SD8 for catalysis
without the necessity for the hydrogen bond from Ser95, and this
likely arises because the active-site cavity of the binary complex
closely matches the shape of the substrate (Figure 3B).
Ile108 contributes to the hydrophobic surface that forms one
side of the active-site cavity and has a nonspecific role in helping
to trap the angucyclinone group against the nicotinamide ring of
the cofactor (Figure 3B). Unsurprisingly, an I108A substitution
had almost no effect, whereas changing it to aspartate (I108D)
abolished activity (Figure 4C). In the latter case, the introduction
of a negative charge would interfere with the hydrophobic envi-
ronment and could disrupt the intramolecular hydrogen bond
in the substrate, both being necessary for catalysis.
Finally, mutation of His112 (H112A, H112N, and H112Q)
strongly reduced or abolished enzyme activity (Figure 4C),
consistent with its key role in binding and positioning the
cofactor via a hydrogen bond to the 20-hydroxyl of the nicotin-
amide ribosyl moiety (Figures 2D, 2E, and 4B).
SIGNIFICANCE
The sequence of SimC7 is distinct from previously charac-
terized polyketide ketoreductases, and the structural data
reported here suggest that it catalyzes a novel substrate-
assisted, two-step reaction for the reduction of the C-7
carbonyl group. Thismechanism involves the intramolecular
transfer of a substrate-derived proton to generate a pheno-
late intermediate, negating the need for proton transfer from
a canonical SDR active-site tyrosine. Like SimC7 (Ser-Ile-
His), the two closest structural homologs, TMR (Tyr-Leu-
His) and QOR2 (Leu-Leu-His), also have unusual active-site
triads. Thus SimC7, TMR, and QOR2 share an I/LxxxH motif
and have substrateswith extensively conjugated pi systems.
No enzyme-substrate complex crystal structures have been
described for TMR or QOR2 and no firm proposals exist for
their catalytic mechanisms, but their substrate structures
and the data provided here suggest they are also likely to
employ noncanonical mechanisms. Our data therefore point
to members of the extended SDR sub-family having I/LxxxH
active site motifs as a source of new biochemistry.
EXPERIMENTAL PROCEDURES
For a full explanation of the experimental protocols, see Supplemental Exper-
imental Procedures.
Protein Overexpression and Purification
Pointmutants of simC7were generated by PCR-based site-directedmutagen-
esis. All constructs were verified by sequencing. Proteins were expressed
in E. coli as N-terminally His-tagged fusions, purified by nickel-affinity chro-
matography and assayed by high-performance liquid chromatography as1096 Cell Chemical Biology 23, 1091–1097, September 22, 2016described previously (Scha¨fer et al., 2015). The structural integrity of purified
proteins was verified using circular dichroism.
Protein Crystallization and Structure Determination
SimC7 was labeled with selenomethionine (SeMet) by metabolic inhibition,
and crystals of both native and SeMet proteins were grown by vapor diffusion
(crystals of binary and ternary complexes were obtained by cocrystallization).
Crystals were harvested and flash-cooled in liquid nitrogen. The native crystals
did not require further cryoprotection, while the SeMet-labeled crystals were
cryoprotected by supplementing the crystallization solution with 25% (v/v)
glycerol. All X-ray data were collected at the Diamond Light Source. For de
novo structure determination, a single-wavelength anomalous dispersion da-
taset was collected at the Se K X-ray absorption edge for an SeMet-labeled
SimC7 crystal. Native and SeMet data were combined to solve the structure
of SimC7 in complex with NADP+. All other structures were determined bymo-
lecular replacement using the latter as a template.
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